BIO-TECHNE Corp (TECH) Stock Price Today
Aura AI Summary
Key Stats
- $11.26BMarket Cap
- -Volume
- HealthSector
- $72.2952W High
- $43.3152W Low
- -Typical Hold Time
- $11.28BEnterprise Value
- 0.44%Div Yield
- -Trading Activity
Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.29, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Most Recent News
Reddit stock set for a major surge after S&P 500 inclusion on August 18, 2026, despite some risks.
Reddit stock has dropped over 22% since early July, making it an attractive buy ahead of its scheduled inclusion in the S&P 500 index on August 18, 2026. This inclusion typically triggers automatic fund buying and significant price spikes, as seen wi...

Pokémon Pokopia sales top 5M on Switch 2, boosting Nintendo shares 7% in Japan
Nintendo announced that Pokémon Pokopia has sold over 5 million units on its Switch 2 console just four months after launch, making it the second-best-selling game on the platform. This strong sales performance helped Nintendo's shares rise 7% in Jap...

Alger Small Cap Growth Fund beats Russell 2000 Growth Index in Q2 2026
The Alger Small Cap Growth Fund's Class A shares outperformed the Russell 2000 Growth Index in the second quarter of 2026. Key contributors to this strong performance included Nebius Group, Astera Labs, and Twist Bioscience, while Insmed, Planet Fitn...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.